Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial - Abbaspour Kasgari, Hamideh; Moradi, Siavash; Shabani, Amir Mohammad; Babamahmoodi, Farhang; Davoudi Badabi, Ali Reza; Davoudi, Lotfollah; Alikhani, Ahmad; Hedayatizadeh Omran, Akbar; Saeedi, Majid; Merat, Shahin; Wentzel, Hannah; Garratt, Anna; et al. (Journal of antimicrobial chemotherapy, 2020)
Keywords: Adult; Aged; Antiviral Agents - administration & dosage; Betacoronavirus; Carbamates; Coronavirus Infections - diagnosis; Coronavirus Infections - drug therapy; Coronavirus Infections - epidemiology; COVID-19; Drug Therapy, Combination; Female; Hospitalization - trends; Humans; Imidazoles - administration & dosage; Iran - epidemiology; Male; Middle Aged; Original Research; Pandemics; Pneumonia, Viral - diagnosis; Pneumonia, Viral - drug therapy; Pneumonia, Viral - epidemiology; Pyrrolidines; Ribavirin - administration & dosage; SARS-CoV-2; Sofosbuvir - administration & dosage; Treatment Outcome; Valine - analogs & derivatives; Iran